United States · FDA National Drug Code directory
NAFCILLIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0338-1019_80c1285d-488f-4901-af11-b867ef156536
- Product NDC
- 0338-1019
- Form
- INJECTION, SOLUTION
- Composition / generic term
- NAFCILLIN
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 19891031
- Source listing expiry
- 20271231
Source-listed ingredients
- NAFCILLIN SODIUM — 2 g/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 BAG (0338-1019-48) · 0338-1019-48
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →